Indian equity markets are witnessing a stark K-shaped divergence, where benchmark indices powered by heavyweight stocks march toward record highs even as the broader market languishes in a deepening correction. Friday's trading session crystallised this troubling split, exposing a market where gains are concentrated in a handful of large-cap blue chips, while thousands of smaller stocks face relentless selling pressure.
The BSE Sensex declined just 0.47% to close at 85,231.92 and the Nifty 50 fell an identical 0.47% to end at 26,068.15—barely a scratch, considering that both indices remain within striking distance of all-time highs
It's a K-shaped market in action, where the fortunes of India's top-200 stocks and the broader universe of mid, small and microcap companies are moving in opposite directions. Earlier this week, Indian equities surged to 13-month highs, with the NIFTY index surpassing 26,200 for the first time since September 2023 and the Sensex climbed above 85,800, closing within 1% of its all-time peak. Yet, this rally was not broad-based—it was orchestrated almost entirely by a handful of heavyweight stocks.
HDFC Bank and Reliance Industries which, together, constitute over 21% of the NIFTY'S weightage, led the charge, with both stocks near their 52-week high. Technology majors also participated, with HCL Technologies, Infosys and TCS, as foreign investors rotated capital from faltering global AI (artificial intelligence) stocks into India's traditional IT services firms. These blue-chip gains created an optical illusion—headline indices suggested a healthy bull market. But peel back the index and the reality is far grimmer. Thousands of mid, small and microcap stocks that don't feature in the Nifty 50 or the Sensex are being systematically battered, caught in a vicious downturn that shows no signs of abating.
The divergence becomes undeniable when examining market breadth indicators which track how many stocks are actually participating in the rally. Moneylife's market breadth indicators have shifted to neutral territory, signalling a renewed loss of momentum and the data reveals a market fragmenting along size lines.
For the Nifty 100—representing India's largest companies—the breadth remains relatively healthy. As of 20th November, 60.78% of stocks trade above their 20-day exponential moving average (EMA), while 72.55% remain above their 50-day as well as 200-day EMAs. These figures, while showing some erosion, still indicate that the index is in bullish territory.
Now contrast that with the Nifty 200 which includes mid-cap representation. Here, the picture darkens considerably. Only 53% of stocks trade above their 20-day EMA—barely half. Just 61.50% remain above the 200-day EMA and 57.50% above the 50-day EMA. The steady decline in these percentages points to increasing internal weakness and thinning participation.
Source: Chartink, Moneylife team
The charts tell an even more damning story. While the percentage of Nifty 100 and Nifty 200 stocks trading above key moving averages has remained relatively stable or declined modestly, the broader market—encompassing the thousands of small and microcap stocks—has collapsed. The number of stocks maintaining uptrends across these segments has plummeted, with many breaking below critical support levels and entering bear market territory. This is the definition of a K-shaped market. On one arm of the ‘K’, India's top-200 blue-chip stocks—benefiting from foreign inflows, institutional support and index inclusion—continue their upward trajectory.
On the other arm of the ‘K’, small-caps and micro-caps are being decimated. These stocks, which had led the market higher through much of 2024, now face relentless selling as liquidity dries up. Retail investors, who disproportionately populate these segments, are bearing the brunt of losses. The erosion in breadth suggests market participation is thinning out dramatically—what was once a broad-based rally has become an increasingly narrow advance powered by index heavyweights.
Source: Chartink, Moneylife team
This concentration of gains in a handful of stocks creates an inherently unstable market structure. When just 20-30 large-caps are responsible for keeping benchmark indices afloat, while thousands of stocks sink, the foundation becomes dangerously narrow. Should these heavyweight leaders stumble—whether due to disappointing earnings, regulatory concerns, or global headwinds—there are few supporting actors to cushion the fall.
Market participants remain cautiously optimistic about large-caps, pointing to robust cash buying, derivatives short-covering and renewed hopes for a prospective US-India trade deal. Open interest in the NIFTY and Bank Nifty contracts has risen significantly, reflecting growing speculative interest in index stocks. Analysts anticipate sustained rally momentum in large-caps like Reliance and HDFC Bank.
But this optimism does not extend to the broader market. The steady decline in stocks trading above key moving averages suggests the recent uptrend in mid and small-caps lacked durability. While headline indices may not yet reflect sharp declines, the underlying structure has weakened considerably, with participation eroding across segments outside the top tier.
IPO Market Thrives amid Dichotomy
Interestingly, India's primary market continues to boom even as the secondary market fragments. Indian firms have raised over ₹1.50 lakh crore through approximately 90 IPOs in 2025, with total IPO-related fundraising reaching ₹1.53 trillion. Lead managers have earned an estimated ₹3,500 crore in fees, and secondary sales via offer-for-sale components have surged to nearly ₹96,000 crore.
Notable exits exceeding ₹15,000 crore this year include stakes sold by Peak XV Partners, SoftBank, Elevation Capital and Accel in companies such as Urban Company, Lenskart, Pine Labs, Groww and Ather Energy. This IPO boom reflects strong appetite for quality assets and newly-listed names, but also highlights how money is flowing into fresh opportunities while existing small-cap holdings face indiscriminate selling.
Greater Caution Warranted
While nearly 65% of major global indices have reached new highs in 2025—suggesting one of the broadest bull phases globally in years—the Indian market tells a different tale. Here, breadth is contracting, not expanding. The rally is becoming more concentrated, not more inclusive.
For retail investors heavily exposed to mid- and small-cap stocks, the message is sobering. The market's K-shaped trajectory means owning the ‘wrong’ stocks—those outside the charmed circle of top blue-chips—has led to significant wealth erosion even as headlines trumpet market highs. This divergence may persist as long as foreign and institutional flows remain concentrated in large-caps, leaving smaller stocks starved of liquidity.
The current market structure warrants greater caution. Beneath the veneer of record highs lies a deeply fractured market, where gains are monopolised by a privileged few while the majority face a grinding bear market. This isn't a healthy bull phase—it's a K-shaped divergence that could presage broader weakness, if and when the large-cap pillar finally cracks.
A White House order revising the reciprocal tariff regime has created a meaningful opening for Indian agricultural exports. The exemption of tropical and specialty products, including coffee, tea and spices, from tariff obligations covers Indian exports valued at an estimated US$548mn (million), potentially enhancing India’s competitiveness in the US market. Key exempted categories include pepper-capsicum preparations (US$181mn) and ginger-turmeric curry spices (US$84mn).
India’s energy sector is defined by structural diversification and tactical manoeuvring around geopolitical risks. Domestic natural gas consumption fell 14.6% in October, driven by elevated international prices and the shift of industrial consumers to cheaper fuels like propane and fuel oil. This, combined with softer crude prices (down from US$72.18 to US$65.08/barrel year-on-year – y-o-y), helped reduce the net oil & gas import bill by 12% to US$69.9bn (billion) in the first seven months of the fiscal year. Simultaneously, US sanctions on key Russian crude suppliers have drastically impacted supplies, with Russian shipments to India plunging 66% in November, averaging just 672,000bpd (barrels per day) compared to 1.88mn in October. Mitigating this supply risk, public sector oil companies have signed their first long-term agreement with the US Gulf Coast to import 2.2MT (million tonnes) of liquefied petroleum gas (LPG), a strategic move expected to increase India's LPG imports by approximately 10% and fortifying the nation's energy diversification strategy
The electronics sector continues to defy a broad merchandise exports slowdown, which saw nine of the top-10 categories contract. Electronics exports expanded 19% y-o-y to ₹4,08,08 crore (US$52.4bn) in October, driven primarily by smartphone shipments which accounted for 60% of the segment's exports. However, the sector faces headwinds from fluctuating demand and rising component costs, with contract manufacturers trimming component imports by as much as 34% post-festive season. Strategically countering this volatility, the ministry of electronics and information technology (MeitY) has sanctioned ₹7,172 crore in investments under the electronic component manufacturing scheme (ECMS). This investment, spread across 17 local firms, is expected to generate production valued at ₹65,111 crore and build indigenous capacity in critical components like multilayer printed circuit boards (PCBs) and camera modules.
In the pharmaceuticals sector, the government is finalising minimum import prices (MIPs) for key raw materials like penicillin-G and amoxicillin to protect domestic active pharmaceutical ingredient (API) manufacturers from predatory pricing by Chinese suppliers, who account for approximately 70% of India’s drug raw material imports, valued at US$3bn–US$4bn. This aligns with the production linked incentive (PLI) scheme. Separately, the drug regulator is enhancing scrutiny on high-risk solvents like propylene glycol, proposing a digital monitoring system via the online national drugs licensing system (ONDLS) portal to track high-risk solvent usage and mitigate contamination risks following cough syrup fatalities.
India’s automotive sector reveals mixed signals. The luxury car market is seeing a notable shift, with salaried professionals and start-up founders now accounting for approximately 30% of BMW’s luxury car sales, nearly tripling their share in five years. Concurrently, electric passenger vehicle retail sales surged 57% y-o-y in October to 18,055 units. The Mahindra group unveiled an ambitious 10-year growth strategy, projecting an eightfold increase in automotive revenue over the decade, primarily driven by sport-utility vehicles (SUVs) and light commercial vehicles (LCVs). Conversely, a vote on CAFE norms revealed a pronounced industry split, with 15 out of 19 car-makers opposing a weight-based exemption (or ‘super credit’) for small cars. Meanwhile, the ministry of heavy industries plans to reduce the PLI scheme allocation for the auto sector for fiscal year (FY) 2026 from ₹2,800 crore to approximately ₹2,000 crore.
This domestic industrial activity is underpinned by substantial public investment in infrastructure. The Indian Railways is set for its highest-ever capital expenditure (capex) allocation of approximately ₹2.76 lakh crore in FY26-27 , a roughly 12% increase aimed at accelerating modernisation and the deployment of 300–400 Vande Bharat trains. Furthermore, states are pushing to nearly double the target for the Pradhan Mantri Gram Sadak Yojana (PMGSY-IV), proposing to connect nearly 50,000 habitations with all-weather roads by 2028-29, building on an initial government funding package of ₹70,125 crore. These State-led demands signal pressure for increased Budgetary allocations or extended timelines.
The telecom regulatory authority of India (TRAI) has mandated that entities in the banking, financial services and insurance (BFSI) sectors adopt the ‘1600’ numbering series for service and transactional calls by phased deadlines starting 1 January 2026. This directive is a direct effort to mitigate fraud, spam and financial scams that exploit conventional 10-digit numbers, following approximately 147mn spam complaints in 2024.
In parallel, private telecom operators are expressing interest in leveraging the government-owned BharatNet fibre infrastructure, valued at nearly ₹40,000 crore, to expand mobile tower and consumer broadband services. However, the government must address quality benchmarks and competitively price access to ensure effective monetisation.
Finally, the Life Insurance Corporation of India (LIC) has called for tax and regulatory reforms to bolster policy sales. Key proposals include classifying insurance services as ‘zero-rated’ under the goods and services tax (GST) framework to allow insurers to claim and recover unutilised input tax credit (ITC), and doubling the tax-free limit on maturity proceeds from the existing ₹5 lakh to ₹10 lakh annual premium to attract high net-worth individual (HNI) customers.
The private sector is scaling up to meet indigenous defence needs, highlighted by Adani Enterprises’ plan to commit between ₹8,000 and ₹10,000 crore to its defence subsidiary. The investment is underpinned by a robust US$1bn order-book and will fund advanced capabilities in unmanned aerial vehicles (UAVs), counter-drone systems and other next-generation products.
The trends of the major indices in the course of the week's trading are given in the table below:
News
Kings Infra Ventures Limited signed an MoU (memorandum of understanding) with the government of Andhra Pradesh. The agreement paves the way for developing a ₹2,500 crore, 500-acre Kings Maritime Aquaculture Technology Park near Srikakulam, close to Visakhapatnam.
Alembic Pharmaceuticals announced that it has secured final approval from the US food and drug administration (US FDA) for its abbreviated new drug application for Diltiazem Hydrochloride tablets USP in 30mg, 60mg, 90mg and 120mg strengths. This approval clears Alembic to market the drug as a therapeutically equivalent version of Cardizem, the reference medicine sold by Bausch Health US, LLC.
Marksans Pharma announced that its wholly-owned UK subsidiary, Relonchem Limited, has received marketing authorisation from the UK’s medicines and healthcare products regulatory agency (MHRA) for two new formulations of Mefenamic Acid. The approvals cover the 250mg and 500mg film-coated tablet variants, expanding the company’s footprint in the UK pharmaceuticals market.
Raymond Lifestyle joined hands with Unicommerce Ltd to bring all its digital retail operations under one unified system. Unicommerce, a leading e-commerce enablement software-as-a-service (SaaS) platform, will help the company simplify and strengthen the way it manages its online business.
Bombay Burmah Trading Corporation Limited (BBTCL) disclosed the termination of its agreement with MSTC (Metal Scrap Trade Corporation). The pact had appointed MSTC as selling agent for BBTCL’s immovable properties via its e-auction platform.
AXISCADES Technologies announced an expanded strategic partnership with Altera Corporation, the leading pure-play FPGA (Field-Programmable Gate Array) provider . The collaboration will focus on developing mission-critical defence applications, strengthening Altera’s engagement in advanced engineering.
AstraZeneca Pharma India and Sun Pharma(-0.29%) have renewed their partnership to expand access to Sodium Zirconium Cyclosilicate (SZC) for hyperkalaemia treatment in India. Under the dual-brand strategy, AstraZeneca will market SZC as Lokelma®, while Sun Pharma will distribute it as Gimliand®. AstraZeneca retains full control over IP (Intellectual Property), marketing authorisation and import licensing, ensuring compliance and continuity.
Max Healthcare Institute announced that around 4,800 beds from its expansion pipeline will be operational in the next three and four years. It currently runs 20 facilities with around 5,200 beds across Delhi NCR, Mumbai, Mohali, Bathinda, Dehradun, Lucknow and Nagpur. The rollout will nearly double capacity positioning Max among India’s largest private hospital networks.
JSW Infrastructure announced a major overseas expansion through its step-down subsidiary, JSW Overseas FZE. The unit has signed an SPA (Share Purchase Agreement) with Minerals Development Oman (MDO) and South Minerals Port Company SAOC (Port SPV) to acquire 51% equity in the Port SPV. On completion, the Port SPV will become a step-down subsidiary of JSW Infrastructure. A shareholders’ agreement with MDO has also been executed to define governance and partner rights, strengthening JSW’s global port footprint.
Greaves Cotton partnered with Europe’s Ligier group to supply advanced quadri-cycle power-trains. The company has developed the 499cc REVO D+ diesel engine, Euro V+ certified, now powering Ligier’s JS50 and Myli microcars.
Mahanagar Telephone Nigam Limited (MTNL)(-1.59%) disclosed continued defaults to seven banks, with dues classified as NPAs since 2024–25. Outstanding obligations total ₹8,881.48 crore, including ₹7,794.34 crore principal and ₹1,087.14 crore interest.
RITES signed an MoU with the Andhra Pradesh economic development board to support large-scale infrastructure and industrial projects. The partnership will leverage RITES’ expertise in feasibility studies, DPRs (Detailed Project Reports), project management, bid process handling and independent audits.
PTC Industries announced a major expansion of its investment casting facility in Mehsana (Gujarat), strengthening its advanced manufacturing base. The move aligns with global supply-chain realignments, as original equipment manufacturers (OEMs) diversify sourcing to trusted destinations like India.
KEC International (KEC) fell on Wednesday after Power Grid Corp (PGCIL) barred it from fresh tenders for nine months. The restriction, linked to a March 2025 bribery case involving a KEC executive and a PGCIL official, prevents new bids until August 2026. KEC clarified that ongoing PGCIL projects remain unaffected and will continue without disruption.
Sammaan Capital’s shares fell on Wednesday after the Supreme Court sharply criticised investigative agencies over their handling of alleged financial irregularities and suspected money laundering. It directed the central bureau of investigation (CBI) to file an FIR (first information report), enabling enforcement directorate (ED) to deepen its money-laundering probe.
Oil India signed a technology service agreement with TotalEnergies. The pact strengthens collaboration in deep and ultra-deepwater exploration across India’s offshore basins. It covers technical support for Andaman gas appraisal, OALP-IX blocks, OALP-X opportunities and stratigraphic drilling.
NBCC (India) closed the sale of 609 residential units in Greater Noida via e-auction. The properties fetched ₹1,069.43 crore in total, reflecting strong demand. NBCC will earn a 1% marketing fee on the overall sale value.
Axis Mutual Fund introduced Micro-Investment™, an industry-first feature enabling investments starting at just ₹100 per scheme. The initiative allows diversification across multiple mutual fund schemes with minimal commitment, easing entry for first-time investors. By lowering barriers, it aims to reduce fear of wrong choices and build confidence through small-value SIPs.
Marksans Pharma, through its US subsidiary, has received final US FDA approval for Loperamide Hydrochloride tablets USP, 2mg. The product is bioequivalent to Imodium A-D (Kenvue Brands LLC) and will now be marketed in the US.
RateGain Travel Technologies unveiled a refreshed brand logo, signalling its shift to an AI-first identity. The new branding reflects its evolution from a single-product platform to a unified travel tech-provider.
Solara Active Pharma Sciences received a positive US FDA update for its Mangalore site, which has been classified as voluntary action indicated (VAI). The inspection noted two procedural observations in Form 483, to which Solara responded within timelines. US FDA’s acceptance of the company’s explanations reinforces its strong compliance culture and credibility as a global active pharmaceutical ingredient (API) supplier.
Sai Life Sciences disclosed a GST demand order from the joint commissioner of commercial taxes (appeals), Kalaburagi. The order raises IGST of ₹20.85 crore, interest of ₹13.75 crore, and penalty of ₹2.08 crore. It relates to intermediary services from its US subsidiary, under reverse charge mechanism, for July 2017–March 2022.
EPack Prefab Technologies signed an MoU with MASCOT South Asia LLP to drive a multi phase capacity expansion in Gujarat. Currently operating at high utilisation, the company plans to add around 50,000 tonnes of PEB capacity in the first phase. This initial phase involves an investment of about Rs110 crore, with later funding structures to be detailed as the project advances.
ACME Solar Holdings commissioned an additional 16MW (megawatt) at its 100MW wind project in Surendranagar (Gujarat). This follows the 28MW brought on stream in October 2025, taking operational capacity to 44MW. With a total installed base of 2,934MW, ACME reinforces its position among India’s leading renewable energy players.
Godrej Properties acquired an additional 3.8 acres on Sarjapur Road, South Bengaluru. The move adds around 2mnsqft (million square feet) of develop-able area, unlocking ₹2,400 crore in incremental revenue potential. With the combined 30-acre parcel, the company plans a premium integrated township offering around 3mnsqft of development.
Orders
Transrail Lighting secured fresh orders worth ₹548 crore, including a major international transmission line engineering-procurement-construction (EPC) project in the MENA (Middle East and North Africa0 region. The win marks its entry into a new geography and strengthens its global expansion strategy. It also reinforces Transrail’s diversified expertise across civil infrastructure, railways, poles & lighting and solar EPC.
Lloyds Engineering Works announced two contract agreements with Poland-based KliverPolska Sp z o.o . under SEBI’s LODR norms. The first deal, worth US$163,900, covers design, prototyping and delivery of towed reels for a multifunctional underwater platform. This marks a strategic addition to Lloyds’ portfolio in specialized engineering solutions.
Goodluck India defence arm secured a US$6mn export order for 155mm M107 Ready to Fill artillery shells. The deal, disclosed under SEBI’s LODR norms, marks a significant addition to its defence manufacturing portfolio.
HG Infra Engineering secured a ₹274.11 crore order from DLF Cyber City Developers Ltd. The project covers infrastructure and access road works at DLF Downtown phase-2, Sector-25A, Gurugram. Construction is scheduled over 548 days, adding to HGINFRA’s expanding portfolio in commercial hub development.
Newgen Software Technologies, via its UK subsidiary, secured a three-year master service agreement worth £1.47mn. The deal covers software licences, AWS-managed cloud services and full implementation support for a UK-based client.
Bondada Engineering signed a five-year framework agreement with the Adani group for large-scale solar energy collaboration. Under the first tranche, Bondada has secured a 650MW order from Adani Green Energy Ltd (AGEL). The partnership ties into Adani’s 30GW Khavda renewable hub in Gujarat.
Solar Industries India announced a significant milestone with export orders worth ₹1,400 crore for defence products, to be executed over four years.
WPIL, through its South African subsidiary, secured a major overseas contract worth 821mn Rand (₹426 crore). The deal, awarded by METSI KE MATLA joint venture (JV), coves complete electro-mechanical and instrumentation works for TCTA’s MCWAP2 Project. Commissioning is slated within 48 months, with WPIL confirming the contract is not a related-party transaction.
Pace Digitek landed a major win with a fresh order worth ₹929.76 crore from Maharashtra State Power Generation Company Limited (MSPGCL).
Saatvik Green Energy received a fresh order worth ₹177.50 crore from a reputed domestic independent power producer/EPC player.
KEC International Ltd announced new order wins worth ₹1,016 crore across its civil, oil & gas pipelines, transmission & distribution (T&D) and cables and conductors businesses.
Investment/ Acquisition / Stake Stale
Bajaj Auto, via its Netherlands arm Bajaj Auto International Holdings BV (BAIH), acquired 100% of Pierer Bajaj AG. With this, Bajaj now indirectly controls around 74.9% of PIERER Mobility AG and KTM AG. The Pierer group has fully exited, giving Bajaj direct strategic control over these leading European motorcycle brands.
Earnings
Siemens Q2FY25-26 results showed a sharp 41.6% y-o-y drop in net profit to ₹485 crore. Revenue rose 16% to ₹5,171 crore, while earnings before interst, taxes, depreciation and amortisation (EBITDA) grew 13.3% to ₹617.8 crore. Margins softened slightly to 12% versus 12.2% last year, reflecting stable operations amid top-line growth.
India Glycols reported revenue of ₹1,092 crore which is up 13.6% from ₹ 961 crore a year ago. EBITDA moved sharply higher as well, rising 36.2% to ₹158 crore compared to ₹116 crore last year. With this, the operating margin also witnessed an improvement, coming in at 14.4% versus 12% earlier.
Optiemus Infracom reported consolidated revenue of ₹418 crore for Q2FY25-26, down 12.2% from ₹477 crore last year. EBITDA rose 16.2% to ₹33.6 crore compared to ₹28.9 crore a year ago, driven by better cost control and improved efficiency. EBITDA margin also inched up to 8%, higher than 6.1% in the same period last year. Net profit for the quarter stood at ₹16.8 crore, marking a 22.2% jump from ₹13.7 crore last year.
Fineotex Chemical’s posted revenue of ₹138 crore for Q2FY25-26 which is lower than the ₹146 crore it reported in the same period last year, marking a drop of 5.5%. Profitability also took a hit, with EBITDA falling to ₹31 crore from ₹36.4 crore, a decline of 14.8%. EBITDA margin narrowed to 22.5% compared to 25% last year. Net profit slid 18.4% to ₹26 crore, down from ₹31.9 crore a year ago.
Siemens reported 16% y-o-y increase in consolidated revenue, at ₹5,171 crore, compared to ₹4,457 crore a year earlier. Operational performance also stayed firm, with EBITDA rising 13.3% y-o-y to ₹617 crore against ₹545 crore in the same period last year. EBITDA margin, however, softened slightly to 11.9%, down from 12.2% previously. Net profit dropped 41.6% y-o-y, falling to ₹485 crore from ₹831 crore.
Inox Wind reported consolidated revenue of ₹1,162 crore, up 56% y-o-y, highlighting strong momentum in its order execution cycle. EBITDA increased 48% to ₹271 crore, while profit before tax rose 93% to ₹169 crore. Profit after tax stood at ₹121 crore, up 43% even after accounting for a ₹49 crore deferred tax charge during the quarter.
Narayana Hrudayalaya posted 30% y-o-y rise in net profit to ₹258 crore. Revenue increased 20% y-o-y to ₹1,644 crore, while EBITDA grew 30% to ₹403 crore. Operating margin improved to 24.5%, up from 22.6% in the same period last year.
Top gainers and losers of the major indices for the week are given in the table below:
